Modulation Therapeutics (United States)
- Research works
- 64 ▲ 38% vs 2018-21
- Citations
- 928 14.5 per fractional work
- Top-10% rate
- 6.3% all institutions 10.0%
- Open access
- 28% world 40%
- International
- 29% world 18%
Not ranked overall: Modulation Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Modulation Therapeutics (United States) work in?
In all years, 46% of research at Modulation Therapeutics (United States) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (37%), Computer Science (4%). It does 2.6× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 17 fields, with their numbers
- Life Sciences2945.9%
- Health Sciences2640.1%
- Medicine2538.5%
- Health Professions11.2%
- Nursing00.4%
- Physical Sciences811.8%
- Computer Science34.3%
- Chemistry23.0%
- Engineering23.0%
- Materials Science11.3%
- Earth and Planetary Sciences00.1%
- Energy00.1%
- Social Sciences12.2%
- Social Sciences11.8%
- Arts and Humanities00.3%
- Psychology00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.1×. Every wedge is a field page.
All 9 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology5.07×2 works
- Immunology and Microbiology3.41×0 works
- Medicine3.14×5 works
- Nursing1.68×0 works
- Neuroscience1.14×0 works
- Agricultural and Biological Sciences0.87×0 works
- Health Professions0.26×0 works
- Psychology0.11×0 works
- Engineering0.09×0 works
Which keywords describe research at Modulation Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, PET Imaging and Targeted Therapy.
- PET/CT
- Neurodegeneration
- Pharmacology
- Cancer Immunotherapy
- Mammalian Cells
- Clinical Trials
- Chemotherapy
- Biomarkers
- Bacterial Therapy
- Arginine Deprivation
- Genetic Mutations
- Tumor Targeting
- Radioimmunotherapy
- Fc Receptors
- Viral Vectors
- Targeted Therapy
- Therapeutic Antibodies
- Inflammation
- Cancer Therapy
- Immunotherapy
- Gene Therapy
- Glycosylation
- Cancer
- Monoclonal Antibodies
- PET Imaging
- AAV
- Antibody Engineering
- Tumor Regression
- Radiopharmaceuticals
- Cell Death
- Monoclonal Antibody
- BRCA Mutation
- PARP Inhibitors
- Transcriptional Regulation
- Apoptosis
- Imaging
- Recombinant Protein
- Innate Immunity
- Drug Discovery
- Nuclear Receptors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Therapy7▲ 41×4 topics
- Immunotherapy6▲ 13×9 topics
- Glycosylation5▲ 38×3 topics
- Cancer Therapy4▲ 10×8 topics
- Cancer4▲ 4.6×13 topics
- Inflammation4▲ 2.7×14 topics
- Monoclonal Antibodies4▲ 41×2 topics
- Therapeutic Antibodies4▲ 46×2 topics
- PET Imaging3▲ 24×2 topics
- Targeted Therapy3▲ 24×3 topics
- AAV3▲ 76×1 topic
- Viral Vectors3▲ 76×1 topic
- Antibody Engineering3▲ 47×1 topic
- Fc Receptors3▲ 47×1 topic
- Tumor Regression3▲ 54×2 topics
- Radioimmunotherapy3▲ 114×1 topic
- Radiopharmaceuticals3▲ 114×1 topic
- Tumor Targeting3▲ 33×3 topics
- Cell Death3▲ 20×3 topics
- Genetic Mutations2▲ 7.4×6 topics
- Monoclonal Antibody2▲ 54×2 topics
- Arginine Deprivation2▲ 81×1 topic
- BRCA Mutation2▲ 215×1 topic
- Bacterial Therapy2▲ 81×1 topic
- PARP Inhibitors2▲ 215×1 topic
- Biomarkers2▲ 5.6×5 topics
- Transcriptional Regulation2▲ 14×4 topics
- Chemotherapy2▲ 4.7×7 topics
- Apoptosis2▲ 8.0×6 topics
- Clinical Trials2▲ 5.0×5 topics
- Imaging2▲ 9.0×3 topics
- Mammalian Cells2▲ 77×1 topic
- Recombinant Protein2▲ 77×1 topic
- Cancer Immunotherapy2▲ 19×2 topics
- Innate Immunity2▲ 7.5×4 topics
- Pharmacology2▲ 8.1×5 topics
- Drug Discovery2▲ 6.5×3 topics
- Neurodegeneration2▲ 7.7×5 topics
- Nuclear Receptors2▲ 13×2 topics
- PET/CT2▲ 31×1 topic
Which research topics does Modulation Therapeutics (United States) publish most on?
By volume in 2022-now: PARP inhibition in cancer therapy, Phosphodiesterase function and regulation, Cholinesterase and Neurodegenerative Diseases and Phytochemistry and biological activities of Ficus species.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 PARP inhibition in cancer therapy Oncology 2 works
- 2 Phosphodiesterase function and regulation Molecular Biology 0 works
- 3 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
- 4 Phytochemistry and biological activities of Ficus species Plant Science 0 works
- 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 6 Ocular Oncology and Treatments Ophthalmology 0 works
- 7 Lung Cancer Research Studies Oncology 0 works
- 8 Cancer therapeutics and mechanisms Molecular Biology 0 works
- 9 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 10 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Modulation Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 38% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Modulation Therapeutics (United States) as a percentage of every work published that year, 0.000014% in 2024.
Fractional works of Modulation Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Tampa
- University of South Florida
- Moffitt Cancer Center
- Shriners Hospitals for Children
- University of Tampa
- Atkins (United States)
- Children's Cancer Center
- AdventHealth Tampa
- Florida Orthopaedic Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Modulation Therapeutics (United States). Posts are plain text and can be reported.